Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting The Nuclear Factor-Kappa (B) - (NF-KB)
申请人:Zhang Jie
公开号:US20120088827A1
公开(公告)日:2012-04-12
The invention relates to compounds of formula (I), formula (II), formula (III) and formula (IV),
and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries.